Product NDC: | 65084-453 |
Proprietary Name: | Hydrocodone Bitatrate and Acetaminophen |
Non Proprietary Name: | Hydrocodone Bitatrate and Acetaminophen |
Active Ingredient(s): | 325; 10 mg/1; mg/1 & nbsp; Hydrocodone Bitatrate and Acetaminophen |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65084-453 |
Labeler Name: | Rx Pak Division of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040148 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130624 |
Package NDC: | 65084-453-10 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (65084-453-10) |
NDC Code | 65084-453-10 |
Proprietary Name | Hydrocodone Bitatrate and Acetaminophen |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (65084-453-10) |
Product NDC | 65084-453 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydrocodone Bitatrate and Acetaminophen |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130624 |
Marketing Category Name | ANDA |
Labeler Name | Rx Pak Division of McKesson Corporation |
Substance Name | ACETAMINOPHEN; HYDROCODONE BITARTRATE |
Strength Number | 325; 10 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |